Cases in the Press

Roche

Swiss pharma giant Roche faces a $60 million tax adjustment after the first court decision involving Australia’s complex transfer pricing rules, which are designed to ensure multinationals pay their fair share of tax.

Read more
Cases in the Press

ExxonMobil

Energy giant ExxonMobil is suing NorthWestern Energy over power outages at its Billings refinery. Exxon claims the outages cost the company millions of dollars.

Read more
Cases in the Press

Egon Zehnder

Global headhunter Egon Zehnder allegedly cheated the city and the state of New York out of millions under a 10-year tax dodge designed to underreport U.S.-based earnings while ginning up illegitimate losses, according to a recently unsealed tax whistleblower complaint.

Read more
Cases in the Press

Eli Lilly

An Illinois jury said Eli Lilly and Co. must pay $61 million in a whistleblower’s fraud suit alleging that the company made false claims about pricing under Medicaid’s drug rebate program.

Read more

November 10, 2022

On November 10, 2022, Dr. Brian Becker provided direct, cross-examination, and “hot tub” testimonies regarding royalty damages in the biopharmaceutical industry at the American Arbitration Association.

October 14, 2022

On October 14, 2022, Dr. Brian Becker served as a panelist for the “Using Experts in State Tax Matters” at the ABA Tax Section 2022 Fall Meeting.

June 15, 2022

On June 15, 2022, Dr. Brian Becker submitted a damages expert report involving a powerplant in Madagascar in an international arbitration dispute at the International Centre for Dispute Resolution.

June 1, 2022

On June 1, 2022, Dr. Brian Becker submitted an expert report to the Central District Court of California concerning class-action damages for fund investments. On July 13, 2022, Dr. Brian Becker provided a deposition testimony for the same case.

May 13, 2022

On May 13, 2022, Dr. Brian Becker provided an expert report dealing with class-action damages to the United States District Court in Southern Ohio in a dispute about the management of an investment fund.

May 11, 2022

On May 11, 2022, Dr. Brian Becker provided an expert report assessing royalty damages in the biopharmaceutical industry to the American Arbitration Association.

March 1, 2022

On March 1, 2022, Dr. Brian Becker provided direct and cross-examination testimony (virtually) to JAMS Arbitration in a case concerning unfair competition.

Cases in the Press
Cases in the Press

Roche

Swiss pharma giant Roche faces a $60 million tax adjustment after the first court decision involving Australia’s complex transfer pricing rules, which are designed to ensure multinationals pay their fair share of tax.

Read more
Cases in the Press

ExxonMobil

Energy giant ExxonMobil is suing NorthWestern Energy over power outages at its Billings refinery. Exxon claims the outages cost the company millions of dollars.

Read more
Cases in the Press

Egon Zehnder

Global headhunter Egon Zehnder allegedly cheated the city and the state of New York out of millions under a 10-year tax dodge designed to underreport U.S.-based earnings while ginning up illegitimate losses, according to a recently unsealed tax whistleblower complaint.

Read more
Cases in the Press

Eli Lilly

An Illinois jury said Eli Lilly and Co. must pay $61 million in a whistleblower’s fraud suit alleging that the company made false claims about pricing under Medicaid’s drug rebate program.

Read more
Archives

November 10, 2022

On November 10, 2022, Dr. Brian Becker provided direct, cross-examination, and “hot tub” testimonies regarding royalty damages in the biopharmaceutical industry at the American Arbitration Association.

October 14, 2022

On October 14, 2022, Dr. Brian Becker served as a panelist for the “Using Experts in State Tax Matters” at the ABA Tax Section 2022 Fall Meeting.

June 15, 2022

On June 15, 2022, Dr. Brian Becker submitted a damages expert report involving a powerplant in Madagascar in an international arbitration dispute at the International Centre for Dispute Resolution.

June 1, 2022

On June 1, 2022, Dr. Brian Becker submitted an expert report to the Central District Court of California concerning class-action damages for fund investments. On July 13, 2022, Dr. Brian Becker provided a deposition testimony for the same case.

May 13, 2022

On May 13, 2022, Dr. Brian Becker provided an expert report dealing with class-action damages to the United States District Court in Southern Ohio in a dispute about the management of an investment fund.

May 11, 2022

On May 11, 2022, Dr. Brian Becker provided an expert report assessing royalty damages in the biopharmaceutical industry to the American Arbitration Association.

March 1, 2022

On March 1, 2022, Dr. Brian Becker provided direct and cross-examination testimony (virtually) to JAMS Arbitration in a case concerning unfair competition.